Skip to content

Clinical trials

Phase 2 Hepatitis B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20042
20052
20061
20073
20081
20102
20121
20131
20141
20151
20185
20204
20215
20223
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated5
Active, not recruiting4
Recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Gilead Sciences5
National Institute of Allergy and Infectious Diseases (NIAID)5
Assembly Biosciences4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of Maryland, Baltimore2
Aligos Therapeutics1
Arbutus Biopharma Corporation1
Arrowhead Pharmaceuticals1
AusperBio Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B45
Hepatitis B, Chronic18
Hepatitis7
HIV Infections5
Carcinoma, Hepatocellular3
Hepatitis C3
Acquired Immunodeficiency Syndrome2
AIDS-Related Opportunistic Infections1
Ascites1
Blood-Borne Infections1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.